Secondary leukemia with a translocation (8;21)?
- PMID: 3162399
- DOI: 10.1016/0165-4608(88)90227-0
Secondary leukemia with a translocation (8;21)?
Abstract
The clinical features and cytogenetic changes of acute myeloid leukemia (AML) developing 10 years after radiotherapy and chemotherapy (for osteosarcoma) are described. Features of both de novo AML [FAB M2 morphology, t(8;21), and "secondary leukemia" (additional cytogenetic changes, resistance to chemotherapy) were present. The importance of differentiation between primary and "therapy-linked" disease, and the difficulties in making such a distinction, are discussed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
